Modafinil-induced orofacial dyskinesia in an elderly patient with refractory bipolar depression

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 22, Issue 4, 2010, Pages

  Maser, Rachel V ^a   Liao, Bruce ^b   Pandya, Rupang ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; MODAFINIL; QUETIAPINE; VENLAFAXINE; ANTIDEPRESSANT AGENT; BENZHYDRYL DERIVATIVE;

AGED; BEDTIME DOSAGE; BIPOLAR DEPRESSION; CASE REPORT; CHRONIC KIDNEY FAILURE; CONSTIPATION; CYCLING; DEPRESSION; DISORIENTATION; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; GERIATRIC PATIENT; HOSPITAL ADMISSION; HUMAN; HYDRATION; LETTER; LIVER FUNCTION TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCUPATIONAL THERAPY; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; SOCIAL ISOLATION; URINE RETENTION; BIPOLAR DISORDER; MOTOR DYSFUNCTION;

AGED; ANTIDEPRESSIVE AGENTS; BENZHYDRYL COMPOUNDS; BIPOLAR DISORDER; HUMANS; MALE; MOVEMENT DISORDERS;

EID: 78149352204     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.22.4.451-n.e26     Document Type: Letter

References (5)

1. Anderson KN, Pilsworth S, Sharples LD, et al: Idiopathic hypersomnia: a study of 77 cases. Sleep 2007; 30:1274-1281
2. Frye MA, Grunze H, Suppes T, et al: A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 2007; 164:1242-1249
3. Young JW: Dopamine D1 and D2 receptor family contributions to modafinil-induced wakefulness. J Neurosci 2009; 29:2663-2665
4. Luborzewski A, Regen F, Schindler F, et al: Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder. J Neuropsychiatry Clin Neurosci 2006; 18:248-249
5. Thobois S, Xie J, Mollion H, et al: Adrafinil-induced orofacial dyskinesia. Mov Disord 2004; 19:965-966